Agilon Health, Inc.
A healthcare services company that partners with independent primary care doctors to care for seniors on Medicare, shifting them from a pay-per-visit model to one that rewards keeping patients healthy. Agilon was formed in 2016 when the private equity firm Clayton, Dubilier & Rice combined several physician-management and tech companies to give these small practices the data tools and contracts of big networks. Fun fact: its name isn't a real word—it's a made-up brand meant to sound "agile," perfect for a firm built on bending the old rules of health care.
Sold 123.42M
Granted 992.0K · Bought 110.0K · Sold 100.0K
Granted 1.57M · Bought 12.0K · Sold 1.33M
Granted 104.0K · Sold 198.6K
Granted 13.9K · Sold 145.9K
Granted 1.23M
Granted 1.81M · Bought 22.3K
Granted 1.62M · Bought 804.7K · Sold 1.01M
Granted 320.0K
Granted 295.1K · Bought 5.5K
Granted 491.7K · Bought 5.4K · Sold 431.4K
Granted 288.7K · Sold 156.3K
Granted 19.5K · Bought 21.7K
Granted 25.9K · Bought 14.9K
Granted 290.1K · Bought 33.3K
Granted 13.9K · Bought 5.0K
Granted 212.5K · Bought 126.0K · Sold 126.2K
Granted 145.2K · Sold 26.3K
Granted 73.5K · Sold 61.5K
Granted 129.0K · Bought 25.0K
Granted 121.9K · Bought 25.1K
Granted 7.7K
Granted 119.7K · Bought 20.0K
Granted 55.4K · Sold 50.0K
Granted 153.3K · Sold 150.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| CD&R Investment Associates IX, Ltd. +1 co-filer10% owner · 5 transactions | — | 100.00Mas of May 2023 | — | — | 123.42M |
| Sell StevenCEO & President, Director · 15 transactions | — | 943.9Kas of Apr 2025 | 992.0K | 110.0K | 100.0K |
| Desai VeeralChief Strategy & Dev. Officer · 40 transactions | — | 502.8Kas of Apr 2024 | 1.57M | 12.0K | 1.33M |
| Halkias TheodoreChief Business Officer · 12 transactions | — | 170.6Kas of Dec 2021 | 104.0K | — | 198.6K |
| Smith Michael LDirector · 3 transactions | — | 163.1Kas of May 2022 | 13.9K | — | 145.9K |
| Williams Ronald ADirector · 8 transactions | — | 149.1K | 1.23M | — | — |
| Schwaneke Jeffrey A.Chief Financial Officer · 13 transactions | — | 141.2K | 1.81M | 22.3K | — |
| Shaker BenjaminChief Markets Officer · 101 transactions | — | 122.8K | 1.62M | 804.7K | 1.01M |
| O'Rourke Timothy PatrickCEO & President, Director · 2 transactions | — | 120.0K | 320.0K | — | — |
| Zamore DeniseChief Legal Officer · 11 transactions | — | 66.1K | 295.1K | 5.5K | — |
| Kornitzer BenjaminChief Med. & Quality Officer · 103 transactions | — | 62.1Kas of Mar 2024 | 491.7K | 5.4K | 431.4K |
| Mansukani SharadDirector · 8 transactions | — | 56.2K | 288.7K | — | 156.3K |
| Richards ClayDirector · 4 transactions | — | 41.2Kas of Apr 2023 | 19.5K | 21.7K | — |
| Bensley TimothyChief Financial Officer · 7 transactions | — | 39.4Kas of Apr 2024 | 25.9K | 14.9K | — |
| Venkatachaliah GirishChief Technology Officer · 19 transactions | — | 38.2K | 290.1K | 33.3K | — |
| Gourdine Michelle ADirector · 3 transactions | — | 18.9Kas of Apr 2022 | 13.9K | 5.0K | — |
| Wulf John WilliamDirector · 13 transactions | — | 16.8K | 212.5K | 126.0K | 126.2K |
| Gertsch TimothyChief Accounting Officer · 19 transactions | — | 14.2K | 145.2K | — | 26.3K |
| Dombro LisaExper. & Innovation Officer · 3 transactions | — | 12.0Kas of Sep 2021 | 73.5K | — | 61.5K |
| McLoughlin KarenDirector · 7 transactions | — | 8.2K | 129.0K | 25.0K | — |
| Battaglia SilvanaDirector · 5 transactions | — | 7.9K | 121.9K | 25.1K | — |
| Kasenchak PriscillaChief Accounting Officer · 2 transactions | — | 7.7Kas of Apr 2023 | 7.7K | — | — |
| McKenzie DianaDirector · 7 transactions | — | 7.6K | 119.7K | 20.0K | — |
| Danieley JoanChief Administrative Officer · 9 transactions | — | 5.4Kas of Dec 2021 | 55.4K | — | 50.0K |
| Sobotka GlennChief Accounting Officer · 4 transactions | — | 5.4Kas of Apr 2022 | 153.3K | — | 150.0K |
| Schnall Richard JDirector · 2 transactions | — | 0as of Sep 2021 | — | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -125.97M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.